BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Assunção H, Jesus D, Larosa M, Henriques C, Matos A, Le Guern V, Rubiño F, da Silva JAP, Rua-Figueroa I, Costedoat-Chalumeau N, Doria A, Inês LS. Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort. Rheumatology (Oxford) 2021:keab895. [PMID: 34864894 DOI: 10.1093/rheumatology/keab895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Banjari M, Touma Z, Gladman DD. Improving measures of disease activity in systemic lupus erythematosus. Expert Rev Clin Immunol 2023;19:193-202. [PMID: 36503376 DOI: 10.1080/1744666X.2023.2156339] [Reference Citation Analysis]
2 Zen M, Gatto M, Doria A. Defining the targets in SLE management: insights and unmet gaps. Ann Rheum Dis 2022:ard-2022-222991. [PMID: 36008131 DOI: 10.1136/ard-2022-222991] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]